A Study to Evaluate the Demographics and Treatment Patterns of Myelofibrosis Patients Treated With Ruxolitinib in Turkey
Clinical trial NCT07357441 · COMPLETED
Trial details
- NCT number
- NCT07357441
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-04-07
- Primary completion
- 2023-06-28
- Enrollment
- 355
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.